The DOI matches its Crossref record.
Radiofrequency Ablation of Liver Tumors: A Systematic Review
Abstract
OBJECTIVES: To systematically review radiofrequency ablation (RFA) for treating liver tumors. DATA SOURCES: Databases were searched in July 2003. STUDY SELECTION: Studies comparing RFA with other therapies for hepatocellular carcinoma (HCC) and colorectal liver metastases (CLM) plus selected case series for CLM. DATA EXTRACTION: One researcher used standardized data extraction tables developed before the study, and these were checked by a second researcher. DATA SYNTHESIS: For HCC, 13 comparative studies were included, 4 of which were randomized, controlled trials. For CLM, 13 studies were included, 2 of which were nonrandomized comparative studies and 11 that were case series. There did not seem to be any distinct differences in the complication rates between RFA and any of the other procedures for treatment of HCC. The local recurrence rate at 2 years showed a statistically significant benefit for RFA over percutaneous ethanol injection for treatment of HCC (6% vs 26%, 1 randomized, controlled trial). Local recurrence was reported to be more common after RFA than after laser-induced thermotherapy, and a higher recurrence rate and a shorter time to recurrence were associated with RFA compared with surgical resection (1 nonrandomized study each). For CLM, the postoperative complication rate ranged from 0% to 33% (3 case series). Survival after diagnosis was shorter in the CLM group treated with RFA than in the surgical resection group (1 nonrandomized study). The CLM local recurrence rate after RFA ranged from 4% to 55% (6 case series). CONCLUSIONS: Radiofrequency ablation may be more effective than other treatments in terms of less recurrence of HCC and may be as safe, although the evidence is scant. There was not enough evidence to determine the safety or efficacy of RFA for treatment of CLM.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cited by
Locoregional therapies in the era of molecular and immune treatments for hepatocellular carcinoma
Llovet, J. M., De Baere, T., Kulik, L., Haber, P. K., Greten, T. F., Meyer, T., & Lencioni, R. (2021) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-020-00395-0 · Cited by 1,044
Epidemiology of hepatocellular carcinoma: target population for surveillance and diagnosis
Tang, A., Hallouch, O., Chernyak, V., Kamaya, A., & Sirlin, C. B. (2018) · Abdominal Radiology · doi:10.1007/s00261-017-1209-1 · Cited by 480
Cho, Y. K., Kim, J. K., Kim, M. Y., Rhim, H., & Han, J. K. (2009) · Hepatology · doi:10.1002/hep.22648 · Cited by 466
Gillams, A., Goldberg, N., Ahmed, M., Bale, R., Breen, D., Callstrom, M., Chen, M. H., Choi, B. I., de Baere, T., Dupuy, D., et al. (2015) · European Radiology · doi:10.1007/s00330-015-3779-z · Cited by 329
Lau, W. Y., & Lai, E. C. H. (2009) · Annals of Surgery · doi:10.1097/sla.0b013e31818eec29 · Cited by 304
Metadata
- Authors
- Sutherland, L. M.
- Venue
- Archives of Surgery
- Publisher
- American Medical Association (AMA)
- Published
- 2006-02-01
- Volume
- 141
- Issue
- 2
- Pages
- 181
- ISSN
- 0004-0010 (ISSN-L)
- OpenAlex
- W2004709760
- Cited by
- 251
- References
- 0
- FWCI
- 19.80
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: Radiofrequency Ablation of Liver Tumors: A Systematic Review. https://app.cochat.ai/papers/10.1001/archsurg.141.2.181
- The paper
- Sutherland, L. M. (2006). Radiofrequency Ablation of Liver Tumors: A Systematic Review. Archives of Surgery. https://doi.org/10.1001/archsurg.141.2.181
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.